Invention Grant
- Patent Title: Substituted amidrazones as intermediates in the process for preparing soluble guanylate cyclase stimulators
-
Application No.: US17954725Application Date: 2022-09-28
-
Publication No.: US12054489B2Publication Date: 2024-08-06
- Inventor: Thomas Storz
- Applicant: Tisento Therapeutics Inc.
- Applicant Address: US MA Cambridge
- Assignee: Tisento Therapeutics Inc.
- Current Assignee: Tisento Therapeutics Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Xin Zhang; James M. Alburger
- Main IPC: C07D487/04
- IPC: C07D487/04

Abstract:
The invention relates to substituted amidrazones represented by Formula (IIA):
or a salt thereof, and their use in novel methods for preparing 3-substituted 1,2,4-triazole compounds.
or a salt thereof, and their use in novel methods for preparing 3-substituted 1,2,4-triazole compounds.
Public/Granted literature
- US20230128639A1 PROCESS FOR PREPARING SOLUBLE GUANYLATE CYCLASE STIMULATORS Public/Granted day:2023-04-27
Information query